3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Lymphoma, Follicular
1
Cognitive Dysfunction
1
Alzheimer Disease
1
Interventions
fasudil
1
durvalumab
1
Sevoflurane
1
Rituximab
1
Radiotherapy
1
Propofol
1
Nivolumab
1
Massage
1
Ketamine
1
Fluorescence Polarization Immunoassay
1
Exercise
1
Echocardiography
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Lymphoma, Follicular
×
fasudil
×
Clear all
NCT06362707
2026-05-04
FEAD
Helse Stavanger HF
Phase 2
Recruiting
200 enrolled